Literature DB >> 7704018

The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice.

F M LaFerla1, B T Tinkle, C J Bieberich, C C Haudenschild, G Jay.   

Abstract

To test whether the hypothesis that the Alzheimer's A beta peptide is neurotoxic, we introduced a transgene into mice to direct expression of this peptide to neurons. We show that the transgene is expressed in brain regions which are severely affected in Alzheimer's disease resulting in extensive neuronal degeneration. Morphological and biochemical evidence indicates that the eventual death of these cells occurs by apoptosis. Coincident with the cell degeneration and cell death is the presence of a striking reactive gliosis. Over 50% of the transgenic mice die by 12 months of age, half the normal life span of control mice. These data show that A beta is neurotoxic in vivo and suggest that apoptosis may be responsible for the accompanying neuronal loss, the principal underlying cellular feature of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7704018     DOI: 10.1038/ng0195-21

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  116 in total

Review 1.  Alzheimer's disease research enters a "new cycle": how significant?

Authors:  A Copani; M A Sortino; F Nicoletti; Stella A M Giuffrida
Journal:  Neurochem Res       Date:  2002-02       Impact factor: 3.996

Review 2.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

3.  Interleukin-1beta-converting enzyme (ICE) and related cell death genes ICErel-II and ICErel-III map to the same PAC clone at band 11q22.2-22.3.

Authors:  J Nasir; J L Theilmann; J P Vaillancourt; N A Munday; A Ali; S Scherer; B Beatty; D W Nicholson; M R Hayden
Journal:  Mamm Genome       Date:  1997-08       Impact factor: 2.957

4.  Amyloid-β Oligomers May Impair SNARE-Mediated Exocytosis by Direct Binding to Syntaxin 1a.

Authors:  Yoosoo Yang; Jaewook Kim; Hye Yun Kim; Nayeon Ryoo; Sejin Lee; YoungSoo Kim; Hyewhon Rhim; Yeon-Kyun Shin
Journal:  Cell Rep       Date:  2015-08-13       Impact factor: 9.423

Review 5.  Dysfunction of amyloid precursor protein signaling in neurons leads to DNA synthesis and apoptosis.

Authors:  Rachael L Neve; Donna L McPhie
Journal:  Biochim Biophys Acta       Date:  2006-10-18

Review 6.  Genetically engineered models relevant to neurodegenerative disorders: their value for understanding disease mechanisms and designing/testing experimental therapeutics.

Authors:  P C Wong; H Cai; D R Borchelt; D L Price
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

Review 7.  Shared cognitive and behavioral impairments in epilepsy and Alzheimer's disease and potential underlying mechanisms.

Authors:  Jeannie Chin; Helen E Scharfman
Journal:  Epilepsy Behav       Date:  2013-01-13       Impact factor: 2.937

8.  Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of Alzheimer's disease.

Authors:  Muthuswamy Anantharaman; Jitbanjong Tangpong; Jeffery N Keller; Michael P Murphy; William R Markesbery; Kelley K Kiningham; Daret K St Clair
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

Review 9.  Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer's Disease Immunotherapy.

Authors:  Jing Liu; Bin Yang; Jun Ke; Wenjia Li; Wen-Chen Suen
Journal:  Drugs Aging       Date:  2016-10       Impact factor: 3.923

Review 10.  Understanding the molecular basis of Alzheimer's disease using a Caenorhabditis elegans model system.

Authors:  Collin Y Ewald; Chris Li
Journal:  Brain Struct Funct       Date:  2009-12-11       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.